April 26, 2022
Seth Lieblich, PhD, is a principal at venture capital firm 8VC focusing on life sciences technologies. He joins the QB3-Berkeley Professional in Residence program on May 6th. Lieblich spoke to…
March 29, 2022
Timothy Day, PhD and UC Berkeley alumnus, is the co-founder and chief scientific officer (CSO) of DNALite Therapeutics. Day will be QB3-Berkeley’s Professional in Residence on April 5, 2022. In…
February 03, 2022
Christine Ring, PhD, JD, is the secretary of Nurix and the company’s general counsel. Ring is joining the QB3-Berkeley Professionals in Residence (PIR) program on Friday, Feburary 11th for two…
January 05, 2022
Elise Kikis, PhD, is a professor of biology and chair of the biology department at the University of the South (Sewanee). Kikis is joining the QB3-Berkeley Professionals in Residence (PIR)…
December 07, 2021
Erin Dueber, Ph.D., a Senior Principal Scientist in the Early Discovery Biochemistry Department at Genentech, spoke with graduate student Samvardhini Sridharan about her science career and how being unafraid to try things played a fundamental role along the way.
October 01, 2021
Faith Dukes, PhD, is the director of K-12 STEM Education and Outreach programs at Lawrence Berkeley National Lab. Dukes is joining the QB3-Berkeley Professionals in Residence (PIR) program on October…
April 27, 2021
Rachel Bernstein, PhD, is a the editor of Science Careers. Bernstein is joining the QB3-Berkeley Professionals in Residence (PIR) program on May 6 and May 13. Graduate students and postdocs may register for Bernstein’s PIR visit here. Bernstein spoke with graduate student Kaydren Orcutt about her journey from science writing to writing about the scientific community, and how her experiences at UC Berkeley helped shape her career.
April 06, 2021
Mike Holmes, PhD, is the Chief Scientific Officer at Ambys Medicines and is joining the QB3-Berkeley Professionals in Residence (PIR) program on April 16th and 23rd. He spoke with PhD student Diana Aguilar Gómez about his career from being a graduate student to industry and his pioneering work in genome editing techniques in gene therapy.